| Allison Hoffman, MD | |
|
825 Nicollet Mall, Suite 1227, Minneapolis, MN 55402-2606 | |
| (612) 339-4843 | |
| Not Available |
| Full Name | Allison Hoffman |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 21 Years |
| Location | 825 Nicollet Mall, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659496586 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 48143 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairview Southdale Hospital | Edina, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Specialists, Pa | 1456248137 | 14 |
News Archive
Vtesse, Inc. announced today that the U.S. Food and Drug Administration has granted its drug candidate, VTS-270 for treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough Therapy designation status. Both the FDA and the European Medicines Agency (EMA) had previously granted Orphan Drug status to VTS-270, which is currently in a pivotal Phase 2b/3 clinical trial.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
Flash floods have "worsened an already chronic humanitarian crisis caused by drought" in central Africa where aid agencies have warned that "10 million people are already facing severe food shortages, particularly in the landlocked countries of Chad and Niger, after a drought led to the failure of last year's crops," the Independent reports.
The ruling by the Supreme Court to uphold most of the health law has put the controversy squarely back on the parties' agendas for the November elections.
Sezary syndrome (SS), an aggressive leukemia of mature T cells, is more complicated at a molecular level than ever suspected, according to investigators from the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
| Entity Name | Dermatology Specialists, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992752117 PECOS PAC ID: 1456248137 Enrollment ID: O20040413000263 |
News Archive
Vtesse, Inc. announced today that the U.S. Food and Drug Administration has granted its drug candidate, VTS-270 for treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough Therapy designation status. Both the FDA and the European Medicines Agency (EMA) had previously granted Orphan Drug status to VTS-270, which is currently in a pivotal Phase 2b/3 clinical trial.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
Flash floods have "worsened an already chronic humanitarian crisis caused by drought" in central Africa where aid agencies have warned that "10 million people are already facing severe food shortages, particularly in the landlocked countries of Chad and Niger, after a drought led to the failure of last year's crops," the Independent reports.
The ruling by the Supreme Court to uphold most of the health law has put the controversy squarely back on the parties' agendas for the November elections.
Sezary syndrome (SS), an aggressive leukemia of mature T cells, is more complicated at a molecular level than ever suspected, according to investigators from the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
| Entity Name | Mill City Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790171171 PECOS PAC ID: 0244550101 Enrollment ID: O20150518001510 |
News Archive
Vtesse, Inc. announced today that the U.S. Food and Drug Administration has granted its drug candidate, VTS-270 for treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough Therapy designation status. Both the FDA and the European Medicines Agency (EMA) had previously granted Orphan Drug status to VTS-270, which is currently in a pivotal Phase 2b/3 clinical trial.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
Flash floods have "worsened an already chronic humanitarian crisis caused by drought" in central Africa where aid agencies have warned that "10 million people are already facing severe food shortages, particularly in the landlocked countries of Chad and Niger, after a drought led to the failure of last year's crops," the Independent reports.
The ruling by the Supreme Court to uphold most of the health law has put the controversy squarely back on the parties' agendas for the November elections.
Sezary syndrome (SS), an aggressive leukemia of mature T cells, is more complicated at a molecular level than ever suspected, according to investigators from the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allison Hoffman, MD 825 Nicollet Mall, Suite 1227, Minneapolis, MN 55402-2606 Ph: (612) 339-4843 | Allison Hoffman, MD 825 Nicollet Mall, Suite 1227, Minneapolis, MN 55402-2606 Ph: (612) 339-4843 |
News Archive
Vtesse, Inc. announced today that the U.S. Food and Drug Administration has granted its drug candidate, VTS-270 for treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough Therapy designation status. Both the FDA and the European Medicines Agency (EMA) had previously granted Orphan Drug status to VTS-270, which is currently in a pivotal Phase 2b/3 clinical trial.
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
Flash floods have "worsened an already chronic humanitarian crisis caused by drought" in central Africa where aid agencies have warned that "10 million people are already facing severe food shortages, particularly in the landlocked countries of Chad and Niger, after a drought led to the failure of last year's crops," the Independent reports.
The ruling by the Supreme Court to uphold most of the health law has put the controversy squarely back on the parties' agendas for the November elections.
Sezary syndrome (SS), an aggressive leukemia of mature T cells, is more complicated at a molecular level than ever suspected, according to investigators from the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
Andrea Lynn Bershow, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 516 Delaware St Se, 4-240, Phillips-wangensteen Bldg., Minneapolis, MN 55455 Phone: 612-625-8625 Fax: 612-624-6678 | |
Richard D Steinberg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2220 Riverside Ave S, Mail Stop 31700a, Minneapolis, MN 55454 Phone: 612-371-1600 Fax: 612-371-1732 | |
Kristen Paige Hook, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3316 W 66th St Ste 200, Minneapolis, MN 55435 Phone: 952-920-3808 Fax: 952-920-8899 | |
Dr. Margareth Pierre-louis, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5000 W 36th St Ste 205, Minneapolis, MN 55416 Phone: 612-268-5005 | |
Dr. Sara Anne Hylwa, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 730 South 8th Street, Department Of Dermatology, Minneapolis, MN 55415 Phone: 612-873-3000 | |
Dr. Maria Kramarczuk Hordinsky, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 516 Delaware Street Se, Clinic 5a, Dermatology Clinic, Minneapolis, MN 55455 Phone: 612-625-5656 Fax: 612-672-7422 | |
Lorie A Skibness, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2220 Riverside Ave S., Ms31700a Healthpartners Riverside Clinic, Minneapolis, MN 55454 Phone: 612-341-5000 Fax: 612-371-1673 |